Clinical Profile and Prescribing Patterns of Therapy in Children with Bronchial Asthma in a Rural Site in the

Gayle Therese K Gonzales-Javier1, Leonila F Dans1, Kristine Tanega-Aliling1

  • 1Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.

Acta Medica Philippina
|February 3, 2025
PubMed

Insights

Pediatric asthma care in the Philippines shows poor adherence to GINA guidelines. Overuse of short-acting beta-agonists (SABA) and underuse of inhaled corticosteroids (ICS) were noted, impacting asthma control.

Area of Science:

  • Pediatric pulmonology
  • Public health
  • Clinical quality improvement

Background:

  • Bronchial asthma is a prevalent chronic childhood illness in primary care.
  • Assessing adherence to asthma clinical practice guidelines indicates the quality of care within universal health care systems.
  • The Philippines' primary care setting faces challenges in managing pediatric asthma effectively.

Purpose of the Study:

  • To characterize the clinical profile of pediatric patients diagnosed with bronchial asthma.
  • To evaluate current asthma treatment prescription patterns in a primary care environment.
  • To assess adherence to Global Initiative for Asthma (GINA) guidelines in pediatric asthma management.

Main Methods:

  • Retrospective cohort study utilizing electronic medical records from the Philippine Primary Care Studies (PPCS).
  • Inclusion criteria: Patients under 19 years old diagnosed with asthma between April 2019 and March 2021.
  • Quality indicators were derived from the 2019 Global Initiative for Asthma (GINA) Guidelines.

Main Results:

  • A cohort of 240 children with asthma (mean age 6 years) was analyzed, showing a slight male predominance.
  • High prescription rates for short-acting beta-agonists (SABA), both inhaled (93.3%) and oral (27.5%), were observed.
  • Underutilization of inhaled corticosteroids (ICS) (5.8%) and overuse of SABA-only treatment (especially in children ≥6 years) were significant findings.
  • Antibiotics were prescribed to 71.3% of patients, often without clear indication according to GINA guidelines.

Conclusions:

  • The study identified suboptimal adherence to GINA guidelines by rural health physicians in managing pediatric asthma.
  • Key issues include the overuse of SABA and underuse of ICS, indicating a need for improved asthma control strategies.
  • Findings highlight critical gaps in pediatric asthma care quality within the studied primary care setting.
Abstract

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
344
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
190
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
2.9K